Neuromyelitis optica (NMOSD) trials in France

In France 9 Also abroad 60

9 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseNot yet taking people in France
Neurogenetics and Multi-omics of Neuroinflammatory Diseases in Multiplex Families to Improve Patients Health
Where
Bron, Nantes, Nice, Paris, Rennes
Age
15 years and over
People
500
Run by
Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT07902479
Phase 3Taking people
A Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
Where
Le Kremlin-Bicetre
Age
2 years to 11 years
People
8 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT05199688 · EU 2023-507817-85-00
Phase 4Not yet taking people in France
Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial
Where
Besancon Cedex, Bron, Caen Cedex 9, Clermont Ferrand Cedex 1, Créteil, Dijon, Grenoble Cedex 9, Libourne Cedex, Lille, Lille Cedex, Montpellier Cedex 5, Nantes Cedex 1, Nice, Nimes Cedex 9, Paris, Paris Cedex 13, Poitiers, Rennes, Rouen Cedex, St Germain En Laye Cedex, Talence, Toulouse, Tours
Age
18 years to 64 years
People
160
Run by
University Hospital, Toulouse
See details and how to joinNCT07818356 · EU 2025-525106-37-00
No phaseTaking people
Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
Where
Paris
People
75 worldwide
Run by
Alexion Pharmaceuticals, Inc.
See details and how to joinNCT06312644
No phaseTaking people
French Registry for Monitoring Pregnancies for Multiple Sclerosis
Where
Amiens, Annecy, Avignon, Besançon, Bordeaux, Brive-la-Gaillarde, Bron, Caen, Chambéry, Clermont-Ferrand, Créteil, Dijon, Épinal, Garches, Gonesse, Grenoble, Le Chesnay, Lille, Limoges, Lyon, Marseille, Montpellier, Mornant, Nancy, Nice, Nîmes, Paris, Poissy, Poitiers, Pontoise, Rennes, Rouen, Saint-Denis, Saint-Herblain, Saint-Lô, Saint-Priest-en-Jarez, Strasbourg, Suresnes, Toulouse, Tours, Villeurbanne
People
1,500 worldwide
Run by
Hospices Civils de Lyon
See details and how to joinNCT03900221
Phase 2Taking people
Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
Where
Le Kremlin-Bicetre
Age
2 years to 17 years
People
15 worldwide
Run by
Amgen
See details and how to joinNCT05549258 · EU 2023-510007-22-00
No phaseTaking people
Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging
Where
Marseille
Age
18 years to 90 years
People
700
Run by
Assistance Publique Hopitaux De Marseille
See details and how to joinNCT07202494
No phaseTaking people
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
Where
Lille, Marseille, Montpellier, Nice, Paris, Rouen, Strasbourg, Toulouse
Age
18 years and over
People
103 worldwide
Run by
Ad scientiam
See details and how to joinNCT05566769
Phase 3Taking people
Azathioprine in MOGAD
Where
Bordeaux, Lille, Lyon, Marseille, Montpellier, Nancy, Nice, Nîmes, Paris, Rennes, Rouen, Saint-Herblain, Strasbourg, Toulouse
Age
18 years and over
People
126
Run by
Hospices Civils de Lyon
See details and how to joinNCT05349006